Assyro AI

Orange Book product · Generic (ANDA)

LEUCOVORIN CALCIUM

LEUCOVORIN CALCIUM

Generic (ANDA)ANDA 207226RX FRESENIUS KABI USA

At a glance

Jul 27, 2018

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 27, 2018

    8 yr ago

  2. Today

Pharmaceutical detail

Active ingredient

LEUCOVORIN CALCIUM

Strength

EQ 500MG BASE/50ML (EQ 10MG BASE/ML)

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS

TE code

Not listed

Application

ANDA 207226

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of LEUCOVORIN CALCIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.